New Directions in Triple-Negative Breast Cancer Diagnostics
A novel PD-L1 assay advances the promise of precision medicine.
Read More
Search Results for: lung cancer
Susan G. Komen Unveils Nearly $26 Million Investment in Research with a Focus on Metastatic Breast Cancer
The 2019 grants focus on key areas that will help the organization halve the current number of breast cancer deaths in the United States by 2026.
Read More
Roche Launches Companion Diagnostic to Identify Triple-Negative Breast Cancer Patients Eligible for Treatment with Tecentriq
The Ventana PD-L1 assay helps identify triple-negative breast cancer patients most likely to benefit from treatment with Tecentriq plus chemotherapy.
Read More
Biodesix and Immodulon Announce Research Collaboration for Pancreatic Cancer Treatment
The partnership will focus on analysis of the circulating proteome of advanced pancreatic cancer patients, using the Biodesix Diagnostic Cortex machine-learning platform.
Read More
Liquid Biopsies Guide Improved Cancer Treatment
Monitoring cancer therapy in real time enables physicians to make smarter treatment decisions.
Read More